Measuring Treatment Effects in Clinical Trials Using Cardiac MRI

Suzanne de Waha; Georg Fuernau; Ingo Eitel; Philipp Lurz; Steffen Desch; Gerhard Schuler; Holger Thiele

doi:10.1007/s12410-011-9069-5

Measuring Treatment Effects in Clinical Trials Using Cardiac MRI

Suzanne de Waha^*, Georg Fuernau, Ingo Eitel, Philipp Lurz, Steffen Desch, Gerhard Schuler, Holger Thiele

^*Corresponding author for this work

University of Leipzig

4 Citations (Scopus)

Abstract

Cardiac MRI (CMR) offers the potential to assess valid and reliable parameters associated with cardiac diseases and the corresponding clinical prognosis. It has therefore emerged as a tool for outcome measures, resulting in lower study sample sizes, shorter duration of clinical studies, and subsequently less trial costs. This review focuses on the theoretical and practical background of CMR in measuring treatment effects in clinical trials.

Original language	English
Journal	Current Cardiovascular Imaging Reports
Volume	4
Issue number	2
Pages (from-to)	98-107
Number of pages	10
ISSN	1941-9066
DOIs	https://doi.org/10.1007/s12410-011-9069-5
Publication status	Published - 01.12.2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Areas and Centers

Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Access to Document

10.1007/s12410-011-9069-5

Cite this

@article{b5109d6e3b0e41769ce2de04d8e9aa70,

title = "Measuring Treatment Effects in Clinical Trials Using Cardiac MRI",

abstract = "Cardiac MRI (CMR) offers the potential to assess valid and reliable parameters associated with cardiac diseases and the corresponding clinical prognosis. It has therefore emerged as a tool for outcome measures, resulting in lower study sample sizes, shorter duration of clinical studies, and subsequently less trial costs. This review focuses on the theoretical and practical background of CMR in measuring treatment effects in clinical trials.",

author = "\{de Waha\}, Suzanne and Georg Fuernau and Ingo Eitel and Philipp Lurz and Steffen Desch and Gerhard Schuler and Holger Thiele",

year = "2011",

month = dec,

day = "1",

doi = "10.1007/s12410-011-9069-5",

language = "English",

volume = "4",

pages = "98--107",

journal = "Current Cardiovascular Imaging Reports",

issn = "1941-9066",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - Measuring Treatment Effects in Clinical Trials Using Cardiac MRI

AU - de Waha, Suzanne

AU - Fuernau, Georg

AU - Eitel, Ingo

AU - Lurz, Philipp

AU - Desch, Steffen

AU - Schuler, Gerhard

AU - Thiele, Holger

PY - 2011/12/1

Y1 - 2011/12/1

N2 - Cardiac MRI (CMR) offers the potential to assess valid and reliable parameters associated with cardiac diseases and the corresponding clinical prognosis. It has therefore emerged as a tool for outcome measures, resulting in lower study sample sizes, shorter duration of clinical studies, and subsequently less trial costs. This review focuses on the theoretical and practical background of CMR in measuring treatment effects in clinical trials.

AB - Cardiac MRI (CMR) offers the potential to assess valid and reliable parameters associated with cardiac diseases and the corresponding clinical prognosis. It has therefore emerged as a tool for outcome measures, resulting in lower study sample sizes, shorter duration of clinical studies, and subsequently less trial costs. This review focuses on the theoretical and practical background of CMR in measuring treatment effects in clinical trials.

UR - https://www.scopus.com/pages/publications/80051811029

U2 - 10.1007/s12410-011-9069-5

DO - 10.1007/s12410-011-9069-5

M3 - Scientific review articles

AN - SCOPUS:80051811029

SN - 1941-9066

VL - 4

SP - 98

EP - 107

JO - Current Cardiovascular Imaging Reports

JF - Current Cardiovascular Imaging Reports

IS - 2

ER -

Measuring Treatment Effects in Clinical Trials Using Cardiac MRI

Abstract

UN SDGs

Research Areas and Centers

Access to Document

Other files and links

Fingerprint

Cite this